Prader-Willi Syndrome
Endocrinology · 2006–2008
3decisions
1medicine
0carried consumer input
0individual submissions
Every decision here pre-dates the consumer comments facility, so no input would be recorded either way.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| somatropin Improvement of body composition and treatment of short stature associated with Prader-Willi Syndrome (PWS) in paediatric patients up to 18 years of age. | Mar 2008 | Recommended with restriction | no section in document |
| somatropin treatment for the improvement of body composition and short stature associated with Prader-Willi Syndrome (PWS) in paediatric patients | Nov 2006 | Not recommended | no section in document |
| somatropin Improvement of body composition and treatment of short stature associated with Prader-Willi Syndrome (PWS) in paediatric patients. | Nov 2006 | Not recommended | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 0 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.